THOMPSON DAVIS & CO., INC. - INTELLIPHARMACEUTICS INTL IN ownership

INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 25 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q1 2018. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q4 2017$2,0002,5000.01%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q1 2018
NameSharesValueWeighting ↓
Atria Investments, Inc 75,895$159,0000.02%
FIRST FOUNDATION ADVISORS 100,900$212,0000.02%
Argent Trust Co 15,121$32,0000.01%
Acrospire Investment Management LLC 1,500$3,0000.00%
Virtu KCG Holdings LLC 33,485$70,0000.00%
SIMPLEX TRADING, LLC 9,846$20,0000.00%
Advisor Group, Inc. 11,791$25,0000.00%
Hudson Bay Capital Management LP 10,000$21,0000.00%
BANK OF AMERICA CORP /DE/ 6$00.00%
WELLS FARGO & COMPANY/MN 1,038$2,0000.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders